MedTrace Logo

Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children

NCT00118807 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1800

Last updated 2006-01-09

No results posted yet for this study

Summary

The purpose of this trial is to compare the effectiveness of three combination treatments for uncomplicated malaria when given in operational settings, without supervision of doses other than the first dose.

Conditions

Interventions

DRUG

Amodiaquine plus artesunate (AQ/AS)

DRUG

Sulfadoxine-pyrimethamine plus chloroquine (SP/CQ)

DRUG

Sulfadoxine-pyrimethamine plus amodiaquine (SP/AQ)

Sponsors & Collaborators

  • Medical Research Council

    collaborator OTHER_GOV

  • National Malaria Control Programme, The Gambia

    collaborator OTHER_GOV

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Sam K Dunyo, PhD · Medical Research Council

  • Paul J Milligan, PhD · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2004-02-29

Countries

  • The Gambia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00118807 on ClinicalTrials.gov